Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹268.05.
29 Oct: open ₹269.90, high ₹269.90, low ₹261.80
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,465 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,90,10349.4% delivered
Suven Life Sciences share news and announcements
803 announcements, routine notices left out, newest first. Page 4 of 17.
Jul 2022
11 Jul · Meeting
11 Jul · Meeting
Jun 2022
24 Jun · Corporate action
24 Jun · Board meeting
May 2022
20 May · Related Party Transaction
7 May · General updates
7 May · General updates
7 May · Results
Apr 2022
1 Apr · Legal
The exchange asked on 31 Mar 2022
Mar 2022
Jan 2022
31 Jan · Business
31 Jan · Results
24 Jan · Board meeting
Oct 2021
25 Oct
25 Oct · Results
18 Oct · Board meeting
11 Oct · Legal
The exchange asked on 8 Oct 2021
Aug 2021
9 Aug · Business
9 Aug · Results
2 Aug · Board meeting
Jul 2021
12 Jul · Meeting
May 2021
4 May · Results
Apr 2021
27 Apr · Board meeting
Mar 2021
Feb 2021
25 Feb · Business
20 Feb · Board meeting
17 Feb · Board meeting
Jan 2021
28 Jan · Results
21 Jan · Board meeting
Dec 2020
28 Dec · Legal
The exchange asked on 24 Dec 2020
16 Dec · Legal
The exchange asked on 15 Dec 2020
Nov 2020
19 Nov · Updates